{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:46:47Z","timestamp":1792504007664,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina de Familia. SEMERGEN"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.semerg.2026.102779","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:53:12Z","timestamp":1778817192000},"page":"102779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Estudio de la asociaci\u00f3n entre la enfermedad hep\u00e1tica metab\u00f3lica y el deterioro de la funci\u00f3n renal: Una revisi\u00f3n sistem\u00e1tica actualizada y metaan\u00e1lisis de estudios prospectivos (2020\u20132025)"],"prefix":"10.1016","volume":"52","author":[{"given":"I.","family":"Salcedo Joven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fern\u00e1ndez Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cinza Sanjurjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semerg.2026.102779_bib0355","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s11739-025-03895-6","article-title":"Global burden and risk factors of MASLD: trends from 1990 to 2021 and predictions to 2030","volume":"20","author":"Huang","year":"2025","journal-title":"Intern Emerg Med."},{"key":"10.1016\/j.semerg.2026.102779_bib0360","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL\u2013EASD\u2013EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"Tacke","year":"2024","journal-title":"J Hepatol."},{"key":"10.1016\/j.semerg.2026.102779_bib0365","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol."},{"issue":"4","key":"10.1016\/j.semerg.2026.102779_bib0370","article-title":"Improving Global Outcomes (KDIGO) CKD Work Group","volume":"105","year":"2024","journal-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease"},{"key":"10.1016\/j.semerg.2026.102779_bib0375","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/ndt\/gfab046","article-title":"Incidence and predictors of non-alcoholic fatty liver disease among patients with chronic kidney disease","volume":"36","author":"Triozzi","year":"2021","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.semerg.2026.102779_bib0380","first-page":"1652","article-title":"Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis","volume":"69","author":"Mantovani","year":"2020","journal-title":"Gut."},{"key":"10.1016\/j.semerg.2026.102779_bib0385","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/HEP.0000000000000329","article-title":"Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study)","volume":"78","author":"Nabi","year":"2023","journal-title":"Hepatology."},{"key":"10.1016\/j.semerg.2026.102779_bib0390","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/j.ajkd.2023.08.016","article-title":"Association of Stroke With Metabolic Dysfunction\u2013Associated Fatty Liver Disease With and Without CKD","volume":"83","author":"Li","year":"2024","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.semerg.2026.102779_bib0395","doi-asserted-by":"crossref","first-page":"630","DOI":"10.4093\/dmj.2021.0130","article-title":"Avance Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease","volume":"46","author":"Seo","year":"2022","journal-title":"Diabetes Metab J."},{"key":"10.1016\/j.semerg.2026.102779_bib0400","article-title":"Coexistence of Metabolic Dysfunction-Associated Fatty Liver Disease and Chronic Kidney Disease Is a More Potent Risk Factor for Ischemic Heart Disease","volume":"12","author":"Miyamori","year":"2023","journal-title":"J Am Hart Assoc."},{"key":"10.1016\/j.semerg.2026.102779_bib0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2023.102780","article-title":"The association between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: A systematic review and meta-analysis","volume":"17","author":"Agustanti","year":"2023","journal-title":"Diabetes Metab Syndr."},{"key":"10.1016\/j.semerg.2026.102779_bib0410","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1111\/liv.16075","article-title":"Clinical outcomes of MAFLD versus NAFLD: A meta-analysis of observational studies","volume":"44","author":"Pennisi","year":"2024","journal-title":"Liver Int."},{"key":"10.1016\/j.semerg.2026.102779_bib0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110563","article-title":"Metabolic dysfunction-associated fatty liver disease can significantly increase the risk of chronic kidney disease in adults with type 2 diabetes","volume":"197","author":"Wei","year":"2023","journal-title":"Diabetes Res Clin Pract."},{"key":"10.1016\/j.semerg.2026.102779_bib0420","doi-asserted-by":"crossref","DOI":"10.2196\/45050","article-title":"The Role of Metabolic Dysfunction\u2013Associated Fatty Liver Disease in Developing Chronic Kidney Disease: Longitudinal Cohort Study","volume":"9","author":"Wei","year":"2023","journal-title":"JMIR Public Health Surveill."},{"key":"10.1016\/j.semerg.2026.102779_bib0425","article-title":"Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study","volume":"8","author":"Jang","year":"2018","journal-title":"Sci Rep."},{"key":"10.1016\/j.semerg.2026.102779_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0299507","article-title":"Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis","volume":"19","author":"Gurun","year":"2024","journal-title":"PLoS One."},{"key":"10.1016\/j.semerg.2026.102779_bib0430","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1400448","article-title":"Correlation between the triglyceride-glucose index and chronic kidney disease among adults with metabolic-associated fatty liver disease: fourteen-year follow-up","volume":"15","author":"Wei","year":"2024","journal-title":"Front Endocrinol (Lausanne)."},{"key":"10.1016\/j.semerg.2026.102779_bib0435","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1080\/00365521.2023.2299304","article-title":"The relationship between alcohol consumption and chronic kidney disease in patients with nonalcoholic fatty liver disease","volume":"59","author":"Zheng","year":"2024","journal-title":"Scan J Gastroenterol."},{"key":"10.1016\/j.semerg.2026.102779_bib0440","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3390\/biomedicines10061245","article-title":"Combined Effects of Chronic Kidney Disease and Nonalcoholic Fatty Liver Disease on the Risk of Cardiovascular Disease in Patients with Diabetes","volume":"10","author":"Chung","year":"2022","journal-title":"Biomedicines."},{"key":"10.1016\/j.semerg.2026.102779_bib0445","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/oby.23459","article-title":"Short-term weight loss decreased the risk of chronic kidney disease in men with incident nonalcoholic fatty liver disease","volume":"30","author":"Hu","year":"2022","journal-title":"Obesity."},{"key":"10.1016\/j.semerg.2026.102779_bib0450","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1111\/dom.15758","article-title":"Impact of non-alcoholic fatty liver disease and fibrosis on mortality and kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A multi-cohort longitudinal study","volume":"26","author":"Zhao","year":"2024","journal-title":"Diabetes Obes Metab."},{"key":"10.1016\/j.semerg.2026.102779_bib0455","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/apt.18213","article-title":"Agile 3+ and Agile 4 scores predict chronic kidney disease development in metabolic dysfunction-associated steatotic liver disease","volume":"60","author":"Jung","year":"2024","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.semerg.2026.102779_bib0460","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.cgh.2023.02.024","article-title":"Validation of a Clinical Risk-based Classification System in a Large Nonalcoholic Fatty Liver Disease Real-world Cohort","volume":"21","author":"Sanyal","year":"2023","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.semerg.2026.102779_bib0465","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/jpn3.12272","article-title":"Renal impairment is prevalent in pediatric NAFLD\/MASLD and associated with disease severity","volume":"79","author":"Mouzaki","year":"2024","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"10.1016\/j.semerg.2026.102779_bib0470","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1093\/ndt\/gfab176","article-title":"Role of non-alcoholic fatty liver disease in the evolution of renal function in patients with diabetes mellitus","volume":"37","author":"Aubert","year":"2022","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.semerg.2026.102779_bib0475","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s10620-021-06955-x","article-title":"Progression of Nonalcoholic Fatty Liver Disease-Associated Fibrosis in a Large Cohort of Patients with Type 2 Diabetes","volume":"67","author":"Noureddin","year":"2022","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.semerg.2026.102779_bib0480","doi-asserted-by":"crossref","first-page":"e3661","DOI":"10.1210\/clinem\/dgac382","article-title":"Fibrosis Risk in Nonalcoholic Fatty Liver Disease Is Related to Chronic Kidney Disease in Older Type 2 Diabetes Patients","volume":"107","author":"Sun","year":"2022","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.semerg.2026.102779_bib0485","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-21039-0","article-title":"Potential link between high FIB-4 score and chronic kidney disease in metabolically healthy men","volume":"12","author":"Kuma","year":"2022","journal-title":"Sci Rep."},{"key":"10.1016\/j.semerg.2026.102779_bib0490","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.gastrohep.2022.11.001","article-title":"Prediction of clinical events by liver stiffness and chronic kidney disease by NAFLD in patients with type-2 diabetes","volume":"46","author":"Rivera-Esteban","year":"2023","journal-title":"Gastroenterol Hepatol."},{"key":"10.1016\/j.semerg.2026.102779_bib0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2023.101454","article-title":"Association between fatty liver index and risk of end-stage renal disease stratified by kidney function in patients with type 2 diabetes: A nationwide population-based study","volume":"49","author":"Chung","year":"2023","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.semerg.2026.102779_bib0500","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s12072-020-10063-9","article-title":"Portal inflammation predicts renal dysfunction in patients with nonalcoholic fatty liver disease","volume":"14","author":"An","year":"2020","journal-title":"Hepatol Int."},{"key":"10.1016\/j.semerg.2026.102779_bib0505","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-040970","article-title":"Systematic review of the impact of non-alcoholic fatty liver disease on mortality and adverse clinical outcomes for individuals with chronic kidney disease","volume":"10","author":"Hydes","year":"2020","journal-title":"BMJ Open."},{"key":"10.1016\/j.semerg.2026.102779_bib0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154874","article-title":"Non-alcoholic fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with prediabetes and diabetes","volume":"124","author":"Li","year":"2021","journal-title":"Metabolism."},{"key":"10.1016\/j.semerg.2026.102779_bib0515","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1111\/liv.15004","article-title":"Incidence of liver-related morbidity and mortality in a population cohort of non-alcoholic fatty liver disease","volume":"41","author":"M\u00e4nnist\u00f6","year":"2021","journal-title":"Liver Int."},{"key":"10.1016\/j.semerg.2026.102779_bib0520","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2022.10443","article-title":"Poor Outcomes of Patients With NAFLD and Moderate Renal Dysfunction or Short-Term Dialysis Receiving a Liver Transplant Alone","volume":"35","author":"Fern\u00e1ndez-Carrillo","year":"2022","journal-title":"Transpl Int."},{"key":"10.1016\/j.semerg.2026.102779_bib0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2022.108226","article-title":"Elastographic parameters of liver steatosis and fibrosis predict independently the risk of incident chronic kidney disease and acute myocardial infarction in patients with type 2 diabetes mellitus","volume":"36","author":"Mikolasevic","year":"2022","journal-title":"J Diabetes Complications."},{"key":"10.1016\/j.semerg.2026.102779_bib0530","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1240099","article-title":"Serum uric acid is related to liver and kidney disease and 12-year mortality risk after myocardial infarction","volume":"14","author":"Heerkens","year":"2023","journal-title":"Front Endocrinol (Lausanne)."},{"key":"10.1016\/j.semerg.2026.102779_bib0535","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.hbpd.2023.08.004","article-title":"Prevalence and risk factors for impaired renal function among Asian patients with nonalcoholic fatty liver disease","volume":"23","author":"Sun","year":"2024","journal-title":"Hepatobiliary Pancreat Dis Int."},{"key":"10.1016\/j.semerg.2026.102779_bib0540","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2024024","article-title":"Comparison of all-cause mortality associated with non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease in Taiwan MJ cohort","volume":"46","author":"Cheng","year":"2024","journal-title":"Epidemiol Health."},{"key":"10.1016\/j.semerg.2026.102779_bib0545","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/liv.15171","article-title":"The burden of NAFLD in type 2 diabetic subjects from the general population: A Nationwide population-based follow-up study (NASHCO)","volume":"42","author":"Nabi","year":"2022","journal-title":"Liver Int."},{"key":"10.1016\/j.semerg.2026.102779_bib0550","first-page":"13","article-title":"Non-Alcoholic Fatty Liver Disease and Its Association with Kidney and Cardiovascular Outcomes in Moderate to Avanced Chronic Kidney Disease","volume":"56","author":"Park","year":"2025","journal-title":"Am J Nephrol."},{"key":"10.1016\/j.semerg.2026.102779_bib0555","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000542914","article-title":"Association between Noninvasive Liver Biomarkers and Graft Outcomes in Kidney Transplantation Recipients","volume":"56","author":"Lee","year":"2025","journal-title":"Am J Nephrol."},{"key":"10.1016\/j.semerg.2026.102779_bib0560","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.cgh.2023.09.018","article-title":"Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies","volume":"22","author":"Chan","year":"2024","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.semerg.2026.102779_bib0565","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.eprac.2022.03.016","article-title":"Metabolic Associated Fatty Liver Disease Increases the Risk of Systemic Complications and Mortality. A Meta-Analysis and Systematic Review of 12 620 736 Individuals","volume":"28","author":"Quek","year":"2022","journal-title":"Endocr Pract."},{"key":"10.1016\/j.semerg.2026.102779_bib0570","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2023-100005","article-title":"Metabolic dysfunction-associated fatty liver disease increases risk of chronic kidney disease: a systematic review and meta-analysis","volume":"1","author":"Zhou","year":"2023","journal-title":"eGastroenterology."},{"key":"10.1016\/j.semerg.2026.102779_bib0575","article-title":"Nonalcoholic fatty liver disease and health outcomes: An umbrella review of systematic reviews and meta-analyses","volume":"13","author":"Zhong","year":"2022","journal-title":"The Adv Chronic Dis."},{"key":"10.1016\/j.semerg.2026.102779_bib0580","doi-asserted-by":"crossref","DOI":"10.1177\/20406223211024361","article-title":"Non-alcoholic fatty liver disease is associated with increased risk of chronic kidney disease","volume":"12","author":"Cai","year":"2021","journal-title":"Ther Adv Chronic Dis."},{"key":"10.1016\/j.semerg.2026.102779_bib0585","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.18459","article-title":"Non-obese non-alcoholic fatty liver disease and the risk of chronic kidney disease: a systematic review and meta-analysis","volume":"12","author":"You","year":"2024","journal-title":"PeerJ."},{"key":"10.1016\/j.semerg.2026.102779_bib0590","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1159\/000514953","article-title":"NASH\/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea","volume":"39","author":"Park","year":"2021","journal-title":"Dig Dis."},{"key":"10.1016\/j.semerg.2026.102779_bib0595","doi-asserted-by":"crossref","first-page":"8996","DOI":"10.1038\/s41598-020-65940-y","article-title":"Decrease in waist-to-hip ratio reduced the development of chronic kidney disease in non-obese non-alcoholic fatty liver disease","volume":"10","author":"Chon","year":"2020","journal-title":"Sci Rep."},{"key":"10.1016\/j.semerg.2026.102779_bib0600","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL\u2013EASD\u2013EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol."},{"key":"10.1016\/j.semerg.2026.102779_bib0605","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol."},{"key":"10.1016\/j.semerg.2026.102779_bib0610","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/ndt\/gfac188","article-title":"Metabolic dysfunction\u2013associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease","volume":"38","author":"Tanaka","year":"2023","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.semerg.2026.102779_bib0615","doi-asserted-by":"crossref","first-page":"801","DOI":"10.21037\/hbsn-23-558","article-title":"Comparative associations of non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease with risk of incident chronic kidney disease: a cohort study","volume":"13","author":"Heo","year":"2024","journal-title":"Hepatobiliary Surg Nutr."},{"key":"10.1016\/j.semerg.2026.102779_bib0620","article-title":"Metabolic dysfunction-associated fatty liver disease and risk of incident chronic kidney disease: A nationwide cohort study","volume":"48","author":"Jung","year":"2022","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.semerg.2026.102779_bib0625","first-page":"525","article-title":"Investigating the Effect of Metabolic Phenotypes on Health Events in Alcoholic and Nonalcoholic Fatty Liver Disease","volume":"11","author":"Fan","year":"2023","journal-title":"J Clin Transl Hepatol."},{"key":"10.1016\/j.semerg.2026.102779_bib0630","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/hepr.14097","article-title":"Metabolic dysfunction-associated steatotic liver disease (SLD) and alcohol-associated liver disease, but not SLD without metabolic dysfunction, are independently associated with new onset of chronic kidney disease during a 10-year follow-up period","volume":"55","author":"Mori","year":"2025","journal-title":"Hepatol Res."},{"key":"10.1016\/j.semerg.2026.102779_bib0635","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12916-023-02891-x","article-title":"The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK Biobank","volume":"21","author":"Hydes","year":"2023","journal-title":"BMC Med."},{"key":"10.1016\/j.semerg.2026.102779_bib0640","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/ndt\/gfac266","article-title":"Association between the fatty liver index and chronic kidney disease: the population-based KORA study","volume":"38","author":"Cai","year":"2023","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.semerg.2026.102779_bib0645","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s12072-023-10486-0","article-title":"Association of MAFLD with end-stage kidney disease: a prospective study of 337,783 UK Biobank participants","volume":"17","author":"Chen","year":"2023","journal-title":"Hepatol Int."},{"key":"10.1016\/j.semerg.2026.102779_bib0650","doi-asserted-by":"crossref","first-page":"102873","DOI":"10.1016\/j.dsx.2023.102873","article-title":"Adherence to healthy lifestyle was associated with an attenuation of the risk of chronic kidney disease from metabolic dysfunction\u2013associated fatty liver disease: Results from two prospective cohorts","volume":"17","author":"Zhang","year":"2023","journal-title":"Diabetes Metab Syndr."},{"key":"10.1016\/j.semerg.2026.102779_bib0655","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1210\/clinem\/dgab641","article-title":"Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China","volume":"107","author":"Liang","year":"2022","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.semerg.2026.102779_bib0660","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.032604","article-title":"Severity and Remission of Metabolic Dysfunction\u2013Associated Fatty\/Steatotic Liver Disease With Chronic Kidney Disease Occurrence","volume":"13","author":"Gao","year":"2024","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.semerg.2026.102779_bib0665","doi-asserted-by":"crossref","first-page":"e3957","DOI":"10.1210\/clinem\/dgab425","article-title":"New Nonalcoholic Fatty Liver Disease and Fibrosis Progression Associate With the Risk of Incident Chronic Kidney Disease","volume":"106","author":"Zuo","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.semerg.2026.102779_bib0670","doi-asserted-by":"crossref","first-page":"8606","DOI":"10.1038\/s41598-021-88025-w","article-title":"Fatty liver index is independently associated with deterioration of renal function during a 10-year period in healthy subjects","volume":"11","author":"Takahashi","year":"2021","journal-title":"Sci Rep."},{"key":"10.1016\/j.semerg.2026.102779_bib0675","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1111\/liv.15674","article-title":"The NAFLD burden on mortality and morbidities in general population: A community-based longitudinal study (NASH-CO study)","volume":"43","author":"Nabi","year":"2023","journal-title":"Liver Int."},{"key":"10.1016\/j.semerg.2026.102779_bib0680","article-title":"Exercise reduces the risk of chronic kidney disease in individuals with nonalcoholic fatty liver disease: A nationwide cohort study","volume":"48","author":"Jung","year":"2022","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.semerg.2026.102779_bib0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.bj.2022.04.003","article-title":"Prognosis of chronic kidney disease in patients with non-alcoholic fatty liver disease: a Northeastern Taiwan community medicine research cohort","volume":"46","author":"Huang","year":"2023","journal-title":"Biomed J."},{"key":"10.1016\/j.semerg.2026.102779_bib0690","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3390\/jcm13061616","article-title":"The Fatty Liver Index's Association with Incident Chronic Kidney Disease in Korean Middle-Aged Adults: A Community-Based Cohort Study","volume":"13","author":"Lee","year":"2024","journal-title":"J Clin Med."},{"key":"10.1016\/j.semerg.2026.102779_bib0695","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00125-021-05627-9","article-title":"Advanced liver fibrosis measured by transient elastography predicts chronic kidney disease development in individuals with non-alcoholic fatty liver disease","volume":"65","author":"Jung","year":"2022","journal-title":"Diabetologia."}],"container-title":["Medicina de Familia. SEMERGEN"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359326000961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359326000961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:06:18Z","timestamp":1783105578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1138359326000961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1138359326000961"],"URL":"https:\/\/doi.org\/10.1016\/j.semerg.2026.102779","relation":{},"ISSN":["1138-3593"],"issn-type":[{"value":"1138-3593","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estudio de la asociaci\u00f3n entre la enfermedad hep\u00e1tica metab\u00f3lica y el deterioro de la funci\u00f3n renal: Una revisi\u00f3n sistem\u00e1tica actualizada y metaan\u00e1lisis de estudios prospectivos (2020\u20132025)","name":"articletitle","label":"Article Title"},{"value":"Medicina de Familia. SEMERGEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semerg.2026.102779","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de M\u00e9dicos de Atenci\u00f3n Primaria (SEMERGEN). Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102779"}}